XTRA:EVTLife Sciences
Evotec (XTRA:EVT) Stock Faces Deeper EBITDA Losses After Guidance Cut
Evotec heads into this earnings day with the stock trading at €3.548, roughly flat over the past week but still sharply weaker over three months. That sets the emotional backdrop, with investors already tired from a long slide before even opening the latest report.
The headline this quarter is not revenue size; it is profitability pressure. H1 adjusted group EBITDA came in at a loss of €42.7m and management cut full year guidance to a deeper adjusted EBITDA loss of €70m to €105m. The market...